This was studied in cervical cancer cell lines (SiHa, HeLa, C33A and CaSki) treated with hyperthermia (42 °C) ± ionizing radiation (2–6 Gy) ± cisplatin (0.3–0.5 μM) ± PARP1-inhibitor (olaparib, 4.0–5.0 μM). Here, PARP1 is linked to cervical carcinoma.